From Omics to Action: NGS Proteomics at the Heart of Precision Medicine

Join us for an insightful session where we explore how NGS proteomics is transforming our understanding of health and disease. Discover how proteomics integrates seamlessly with genomics, metabolomics, and transcriptomics to uncover critical connections between environmental exposures, metabolic health, and disease outcomes.

 

In this new Olink Multiomics Coffee Break webinar, we’ll present two compelling case studies powered by Olink® Explore.

 

 

This study explores gene-disease associations by incorporating proteomics data into human and toxicological studies, providing new insights into potential health risks. It examines the associations between per- and polyfluoroalkyl substances (PFAS) exposure and sleep disruption in young adults and assesses how PFAS may impact sleep through metabolic and immune pathways.

 

This integrated approach, combining human epidemiological studies, proteomics data, and toxicological data, can help identify potential biomarkers linked to PFAS-induced sleep disturbances.

 

 

This study investigates proteomic biomarkers in Type 2 diabetes (T2D) remission, specifically in adolescents undergoing bariatric surgery. By analyzing plasma samples collected before and after surgery, researchers identified prognostic biomarkers that could predict the likelihood of T2D remission five years post-surgery. By leveraging prior knowledge from the UK Biobank T2D study, the current prediction framework offers deeper insights into the broader implications of these findings.

 

This Olink Proteomics-based approach provides a comprehensive view of biological processes, paving the way for future integration with genomics, metabolomics, and transcriptomics to further advance our understanding of T2D progression and potential interventions.

 

What You'll Learn:

 

Register now and be part of the multiomics revolution!

 

Organized in collaboration with Fulgent